Table 2 Results of cytotoxic activity screened against HepG2 cell line as IC50 in μM.

From: New proapoptotic chemotherapeutic agents based on the quinolone-3-carboxamide scaffold acting by VEGFR-2 inhibition

Compound No.

R1

R2

IC50 (μM)*

10a

Cl

H

4.60 ± 0.28

10b

Cl

4-CH3

50.83 ± 3.16

10c

Cl

3-CH3

4.14 ± 0.25

10d

Cl

2-CH3

1.07 ± 0.06

10e

Cl

4-F

0.88 ± 0.05

10f

Cl

3-CF3

62.02 ± 3.87

10g

Cl

4-CN

43.15 ± 2.59

10h

Cl

4,5-thiazolyl

14.94 ± 0.52

10i

Cl

4-isopropyl

1.60 ± 0.17

10j

F

H

41.91 ± 2.52

10k

F

4-CH3

34.21 ± 2.06

10l

F

3-CH3

14.18 ± 0.82

10m

F

2-CH3

13.01 ± 0.75

10n

F

4-F

2.88 ± 0.14

10o

F

3-CF3

2.76 ± 0.1

10p

F

4-isopropyl

8.14 ± 0.47

Sorafenib

8.38 ± 0.5

  1. *IC50 values are the average of 3 independent runs ± SE.